A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry Eye
NCT02951910 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2016-11-01
Summary
Hyaluronic acid, a natural polymer, helps to maintain ocular surface hydration and can already be found in several artificial tears recommended to alleviate symptoms of dry eye. A recent hyaluronate modification involves zinc-hyaluronate complex formation by adding zinc-chloride to an aqueous sodium-hyaluronate resulting in a very stable molecular structure, which functions as both a mechanical barrier and a biocompatible film on the ocular surface. Apart from its beneficial elastoviscous characteristics, previous results indicate that hyaluronate can also reduce the excitability of the peripheral nociceptor endings underlying pain. Although hyaluronate is widely used in artificial tears to improve tear film stability, its effect on ocular surface sensitivity was not evaluated in patients with dry eye. The aim of this study is to investigate the characteristics of ocular surface sensations and corneal sensitivity in dry eye patients before and after long-term tear supplementation with zinc-hyaluronate.
Conditions
- Dry Eye
Interventions
- DEVICE
-
Ophylosa tear supplement
Tear film dynamics is assessed by non-invasive tear film breakup time (NI-BUT) in parallel with continuous recordings of ocular sensations during forced blinking. Corneal sensitivity thresholds to selective stimulation of corneal mechanonociceptors, thermal receptors and chemical nociceptors are assessed using the Belmonte gas esthesiometer. All baseline measurements are repeated after one month of tear supplementation with zinc-hyaluronate (Ophylosa eye drop) 4x/day
Sponsors & Collaborators
-
Semmelweis University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2016-08-31
- Completion
- 2016-10-31
More Related Trials
-
Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye
NCT01959854 ·Status: COMPLETED ·Phase: NA
-
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops
NCT00001731 ·Status: COMPLETED ·Phase: PHASE2
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
NCT02326090 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02824913 ·Status: TERMINATED ·Phase: PHASE2
-
Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
NCT03617315 ·Status: COMPLETED ·Phase: NA
-
Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye Discomfort
NCT05777798 ·Status: COMPLETED
-
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
NCT02004067 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants
NCT06851364 ·Status: COMPLETED ·Phase: PHASE2
-
PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825586 ·Status: COMPLETED ·Phase: NA
-
Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients
NCT02533154 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
NCT06860659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
NCT02634853 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
NCT05411367 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02831387 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
NCT01135511 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients
NCT06942793 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
NCT03334539 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of PG101 for Dry Eye Syndrome
NCT02078661 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Study on Safety and Performance of an Artificial Tear in Dry Eye Treatment in Subjects With Ocular Surface Inflammation
NCT04633863 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2